Solid Lipid Nanoparticles of Platycladus orientalis L. possessing ۵-alpha Reductase Inhibiting Activity for Treating Hair Loss and Hirsutism

  • سال انتشار: 1403
  • محل انتشار: مجله گیاهان دارویی و محصولات فرعی، دوره: 13، شماره: 1
  • کد COI اختصاصی: JR_JJMPB-13-1_024
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 76
دانلود فایل این مقاله

نویسندگان

Sara Daneshmand

Department of pharmaceutics, faculty of pharmacy, Zabol University of Medical Sciences, Zabol, Iran

Mitra Niazi

Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Bahman Fazeli-Nasab

Department of Agronomy and Plant Breeding, Agriculture Institute, Research Institute of Zabol, Zabol, Iran

Javad Asili

Department of pharmacognosy, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Shiva Golmohammadzadeh

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

R. Z. Sayyed

Department of Microbiology, PSGVP Mandal’s S I Patil Arts, G B Patel Science and STKV Sangh Commerce College, Shahada ۴۲۵۴۰۹, India

چکیده

Hair loss and hirsutism have been major complaints due to increased concentrations of dihydrotestosterone. The plant Platycladus orientalis, with ۵-alpha reductase inhibitor properties, has been used to treat these disorders. Its formulation with lipophilic carriers in SLN possesses high loading capacity and greater permeability to hair follicles. The present study aimed to determine the content of active ingredients in the extract of P. orientalis L. and to prepare and characterize the solid lipid nanoparticles (SLN) of Platycladus orientalis L. extract as a ۵-alpha reductase inhibitor. The total methanolic extract was obtained following the maceration technique. This preparation was analyzed by HPLC using Quercetin and Cedrol as standard components. SLNs were prepared by high-shear homogenization and ultrasound. Four Glucire-GMS-Compritol-Precirol lipids and three poloxamer-tween۸۰-Labrasol surfactants were further used in the formulations. Particle size, zeta potential, nanoparticle morphology, encapsulation percentage, crystal structure, physical stability, size, and zeta potential were studied ۰, ۳, and ۶ months after preparation. Within ۱-۷ days after preparation, formulations containing GMS and compritol lipids became solid and jelly. Meanwhile, the formulations with Precirol as the lipid and Poloxamer as the surfactant with ۰.۳% extract exhibited desirable properties such as average particle size (۱۹۲ nm), the encapsulation of the extract inside the nanoparticles was almost ۷۱%, and good zeta potential. This formulation containing precirol as a lipid, poloxamer as a surfactant, and ۰.۳% plant extract exhibited greater ۵-alpha reductase inhibitor activity, and it can be recommended to treat hair loss and hirsutism.

کلیدواژه ها

Cedrol, hair loss, hirsutism, HPLC, solid-lipid nanoparticles

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.